Delivery Order SPE2DB24D8002-SPE2DB25FJNQL

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, including medications such as Entresto, Trulicity, Mounjaro, Stelara, and Dupixent, as well as various vaccines. The total ceiling value of the contract is $3,705.97, and it has an ultimate completion date of April 23, 2025. The contract is part of the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of various pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, valued at $1,837.68, is a firm fixed-price delivery order that is part of the DLA Troop Support Medical's ECAT Generation V Program, a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, valued at $2,638.27, is a firm fixed-price delivery order contract with a period of performance through December 9, 2024. The contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA,...
The federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical under the ECAT Generation V Program. The firm fixed-price delivery order, valued at $1,291.82, is for the supply of the prescription drug Trulicity (1.5 mg/0.5 ml pen) with an ultimate completion date of August 22, 2024. This contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNU, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including items such as Trulicity, Mounjaro, Entresto, Stelara, Dupixent, and various vaccines. The contract is an Indefinite Delivery Contract (IDC) that is part of the DLA Troop...
This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,003.07, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support U.S. Armed Forces medical operations. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a $999,999,999.00 Indefinite Delivery Contract (IDC) that allows Dakota Drug to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The specific award is for...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The contract is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,539.84 and a period of performance through February 11, 2025. Dakota Drug, Inc. also holds a larger single-award Indefinite Delivery Contract (IDC)...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNQL
    Delivery Order

This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The contract is for the delivery of pharmaceutical products, including medications such as Trulicity, Mounjaro, Entresto, Stelara, Dupixent, and various vaccines, to support U.S. Armed Forces medical operations. The contract has a firm fixed price, a ceiling value of $2,785.81, and a performance period ending on April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with Dakota Drug, Inc., valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to the DLA.

Generated 7/29/25, 9:46 AM